Brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus with new acute neurological symptoms

Journal of Magnetic Resonance Imaging

Volumn 26, Issue 3, 2007, Pages 541-551

  Welsh, Robert C ^a,c   Rahbar, Habib ^a   Foerster, Bradley ^a   Thurnher, Majda ^b   Sundgren, Pia C ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

^c Kresge III   (United States)

Author keywords

ADC; DWI; Histogram; Lupus; NPSLE

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; GRAY MATTER; HISTOGRAM; HUMAN; MALE; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; WHITE MATTER; ACUTE DISEASE; BRAIN; DIFFUSION; ECHO PLANAR IMAGING; MENTAL DISEASE; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

PROTON;

ACUTE DISEASE; ADULT; BRAIN; DIFFUSION; DIFFUSION MAGNETIC RESONANCE IMAGING; ECHO-PLANAR IMAGING; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; MENTAL DISORDERS; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PROTONS;

EID: 35248871127     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21036     Document Type: Article

References (44)

1. Kovacs J, Urowitz M, Gladman D. Dilemmas in neuropsychiatric lupus. Rheum Dis Clin N Am 1993;19:795-819.
2. Denburg SD, Behmann SA, Carbotte RM, Denburg JA. Lymphocyte antigens in neuropsychiatric systemic lupus erythematosus. Relationship of lymphocyte antibody specificities to clinical disease. Arthritis Rheum 1994;37:369-375.
3. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
4. Wasserman BA, Stone JH, Hellman DB, Pomper MG. Reliability of normal findings on MR imaging for excluding the diagnosis of vasculitis of the central nervous system. AJR 2001;177:455-459.
5. Jennings JE, Sundgren PC, Attwood J, McCune J, Maly P. Value of brain MRI in SLE patients presenting with neurologic symptoms. Neuroradiology 2004;46:15-21.
6. Pomper M, Miller T, Stone J, Tidmore W, Hellman D. CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. AJNR Am J Neuroradiol 1999;20:75-85.
7. McCune J, MacGuire A, Aisen A, Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 1988;31:159-166.
8. Jacobs L, Kinkel P, Costello PB, Alukal MK, Kinkel WR, Green FA. Central nervous system lupus erythematosus: the value of magnetic resonance imaging. J Rheumatol 1988;15:601-606.
9. Sibbitt WL Jr, Sibbitt RR, Griffey RH, Eckel C, Bankhurst AD. Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis 1989;12:1014-1022.
10. Moseley M, Cohen Y, Kucharczyk J, et al. Diffusion-weighted MR-imaging of anisotropic water diffusion in cat central nervous system. Radiology 1990;176:439-445.
11. Le Bihan D. Molecular diffusion nuclear magnetic resonance imaging. Magn Reson Q 1991;7:1-30.
12. Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol 2003;45:169-184.
13. Moseley ME, Kucharczyk J, Mintorovitch J, et al. Diffusion-weighted MR imaging of acute stroke: correlation with T2-weigthed and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol 1990;11:423-429.
14. Lansberg MG, Norbash AM, Marks MP, Tong DC, Moseley ME, Albers GW. Advantages of adding diffusion-weighted magnetic resonance imaging to conventional magnetic resonance imaging for evaluating acute stroke. Arch Neurol 2000;57:1311-1316.
15. Larsson HBW, Thomsen C, Fredriksen J, Stubgaard M, Henriksen O. In vivo magnetic resonance diffusion measurements in the brain of patients with multiple sclerosis. Magn Reson Imaging 1992;10:7-12.
16. Horsfield MA, Lai M, Webb S, et al. Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance. Magn Reson Med 1996;36:393-400.
17. Christensen P, Gideon P, Thomsen C, Stubgaard M, Henriksen O, Larsson HBW. Increased water self-diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis. Acta Neurol Scand 1993;87:195-197.
18. Nakahara M, Ericsson K, Bellander BM. Diffusion-weighted MR and apparent diffusion coefficient in the evaluation of severe brain injury. Acta Radiol 2001;42:365-369.
19. Sundgren PC, Reinstrup P, Romner B, Holtas S, Maly P. Value of conventional, and diffusion- and perfusion weighted MRI in the management of patients with unclear cerebral pathology, admitted to the intensive care unit. Neuroradiology 2002;44:674-680.
20. Stadnik T, Chaskis C, Michotte A, et al. Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. ANJR Am J Neuroradiol 2001;22:969-976.
21. Kono K, Inoue Y, Nakayama K, et al., The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001;22:1081-1088.
22. Sundgren PC, Edvardssson B, Holtas S. Serial investigation of perfusion disturbances and vasogenic oedema in hypertensive encephalopathy by diffusion and perfusion weighted imaging. Neuroradiology 2002;44:299-304.
23. Hinchey J, Chaves C, Applgnani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
24. Bosma GPTh, Huizinga TWJ, Mooijaart SP, van Buchem MA. Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus. AJNR Am J Neuroradiol 2003;24:850-854.
25. Wilson M, Morgan PS, Lin X, Turner BP, Blumhardt LD. Quantitative diffusion weighted magnetic resonance imaging, cerebral atrophy, and disability in multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:318-322.
26. Wilson M, Trench CR, Morgan PS, Blumhardt LD. Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability. J Neurol Neurosurg Psychiatry 2003;74:203-207.
27. Tan E, Cohen A, Fries J, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277.
28. Jenkinson M, Bannister PR, Brady JM, Smith SM. Improved optimisation for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002;17:825-841.
29. Ashburner J, Friston KJ. Multi-modal image coregistration and partitioning - a unified framework. Neuroimage 1997;6:209-217.
30. Sibbitt Jr WL, Haseler LJ, Griffey RR, Friedman SD, Brooks WM. Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. AJNR Am J Neuroradiol 1997;18:1271-1277.
31. Hanly JG, Walsh NM, Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol 1992;19:732-741.
32. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 1968;47:337-369.
33. Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathological findings in 57 cases 1955-1977. Semin Arthritis Rheum 1979;8:212-221.
34. Zvaifler NJ, Bluestein HG. The pathogenesis of central nervous system manifestations of systemic lupus erythematosus. Arthritis Rheum 1982;25:862-866.
35. Pinching AJ, Travers RL, Hughes GR, Jones T, Moss S. Oxgygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus. Lancet 1978;1:898-900.
36. Kushner MJ, Chawluk J, Fazekas F, et al. Cerebral blood flow in systemic lupus erythematosus with and without cerebral complications. Neurology 1987;37:1596-1598.
37. Kovacs JA, Urowitz MB, Gladman DD, Zeman R. The use of single photon emission computerized tomography in neuropsychiatric SLE: a pilot study. J Rheumatol 1995;22:1247-1253.
38. Falconi F, De Cristofaro MT, Ermini M, et al. Regional cerebral blood flow in juvenile systemic lupus erythematosus: a prospective SPECT study. Single photon emission computed tomography. J Rheumatol 1998;25:583-588.
39. Kao CH, Lan JL, ChangLai SP, Liao KK, Yen RF, Chieng PU. The role of FDG-PET. HMPAO-SPECT and MRI in the detection of brain involvement in patients with systemic lupus erythematosus. Eur J Nucl Med 1999;26:129-134.
40. Bosma GPTh, Rood MJ, HuizingaTWJ, De Jong BA, Bollen ELEM, Van Buchem MA. Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus using magnetization transfer imaging. Arthritis Rheum 2000;43:2428-2436.
41. Brooks WM, Sabet A, Sibbitt Jr WL, et al. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J Rheumatol 1997;24:2323-2329.
42. Chinn RJS, Wilkinson ID, Hall-Craggs MA, et al. Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:36-46.
43. Sundgren PC, Jennings J, Attwood TJ, McCune W, Gebarski S, Maly P. MRI and 2D-MR CS1 spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus. Neuroradiology 2005;47:576-585.
44. Kanji GK. 100 statistical tests. Thousand Oaks, CA: Sage Publications; 1993. 68 p.